Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Demographic and anthropomorphic characteristics of the study population.

More »

Table 1 Expand

Table 2.

Spirometry results.

More »

Table 2 Expand

Figure 1.

Exercise physiology of O2 Uptake.

Panel A: Maximum VO2 (VO2-Peak/ABW) normalized with actual individual weight in kg. Panel B: Maximum VO2 (VO2-Peak/IBW) normalized with individual ideal body weight in kg. CTL = healthy normal weight subjects. OB-CTL = obese subjects without a diagnosis of asthma. OB-Asthma = obese subjects with a diagnosis of asthma. N = 10 in each group. n.s. indicates p value not significant. † unadjusted p value significant, ‡ Bonferroni adjusted p value assuming 3 hypothesis tests significant.

More »

Figure 1 Expand

Table 3.

Comparison of cardiopulmonary stress test (CPT) results.

More »

Table 3 Expand

Figure 2.

Pulmonary Physiology.

Panel A: VE = maximum minute ventilation achieved and measured by continuous spirometry circuit during the exercise. Panel B: Pulmonary Reserve = percentage of unused MVV at the peak of exercise by a formula [%PR = (1−VE-Peak/MVV)×100]. CTL = healthy normal weight subjects. OB-CTL = obese subjects without a diagnosis of asthma. OB-Asthma = obese subjects with a diagnosis of asthma. N = 10 in each group. n.s. indicates p value not significant. † unadjusted p value significant, ‡ Bonferroni adjusted p value assuming 3 hypothesis tests significant.

More »

Figure 2 Expand

Figure 3.

Changes in the FEV1 from pre to post CPET.

Percentage changes in FEV1 before and immediately after administering CPET. Thick dotted line = twelve percent reduction in FEV1. N = 10 in each group. CTL = healthy normal weight subjects. OB-CTL = obese subjects without a diagnosis of asthma. OB-Asthma = obese subjects with a diagnosis of asthma. n.s. indicates p value not significant.

More »

Figure 3 Expand

Table 4.

Comparison of VE, %PR, eNO, and IgE results.

More »

Table 4 Expand